Royal jelly significantly alters inflammasome pathways in patients with chronic hepatitis B. Indian Journal of Experimental Biology (IJEB), [S. l.], v. 60, n. 11, p. 875–879, 2022. DOI: 10.56042/ijeb.v60i11.60264. Disponível em: https://or.niscpr.res.in/index.php/IJEB/article/view/1427. Acesso em: 13 may. 2026.